Insights into the Industry
The cancer biomarkers industry has been witnessing optimal growth in recent years and is likely to continue even in upcoming years. The growth of cancer biomarkers ’s industry size can be attributed to rising investments in research & development activities, entry of new players, product innovation, technological breakthroughs, effective allocation of resources, and growing competition among business rivals to expand its regional as well as customer base. Supportive government policies and incentives, as well as favorable laws, are projected to determine the growth of the cancer biomarkers market in foreseeable future. An increase in the spending capacity of customers with the rise in disposable income will further contribute towards cancer biomarkers 's market proceeds.
This market research report is a comprehensive overview of the events taking place in the cancer biomarkers industry and impacting its growth. Our report divides the cancer biomarkers market into various segments or categories based on products, applications, region, etc. Additionally, our research analysts have listed the key players of the global cancer biomarkers market and compared them based on metrics such as market revenue, Y-O-Y sales, shipments volume, historical data, and successful implementation of business strategies such as strategic alliances, mergers & acquisitions, joint ventures, product development, and partnerships & collaborations.
Market Research Store (MRS) published a brand new report titled “Cancer Biomarkers Market research report which is segmented by Products (Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers), by Applications (Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others), by Key Players/Companies QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, Exact Sciences Corporation, Sysmex Corporation, Quest Diagnostics, Agilent Technologies, Hologic, Abbott Laboratories, F.Hoffmann-La Roche Ltd, Roche Diagnostics, Bristol-Myers Squibb Company, Becton Dickinson and Company, Biomérieux SA, Merck KGaA, Illumina”. In 2020, the global cancer biomarkers market value was registered at XX (USD Million/Billion) and is predicted to reach XX (USD Million/Billion) at a CAGR of XX% by 2028.
Request Free SampleScope of the report
| Report Attributes | Report Details |
|---|---|
| Report Title | Cancer Biomarkers Market Research Report |
| By Products | Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers |
| By Applications | Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others |
| By Key Players | QIAGEN, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc, Exact Sciences Corporation, Sysmex Corporation, Quest Diagnostics, Agilent Technologies, Hologic, Abbott Laboratories, F.Hoffmann-La Roche Ltd, Roche Diagnostics, Bristol-Myers Squibb Company, Becton Dickinson and Company, Biomérieux SA, Merck KGaA, Illumina |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East And Africa (MEA) |
| Countries Covered | North America : U.S and Canada Europe : U.K, Spain, Germany, Italy, Russia, France, Rest of Europe APAC : Japan, India, China, Australia, South Korea, South East Asia, Rest of Asia Pacific Latin America : Mexico, Brazil The Middle East And Africa : South Africa, UAE, Saudi Arab, Rest of MEA |
| Base Year | 2020 |
| Historical Year | 2016to 2020 (Depending on availability, data from 2010 can be offered) |
| Forecast Year | 2028 |
| Number of Pages | 105 |
| Customization Available | Yes, the report can be tailored to meet your specific requirements. |
Based on these findings, the global cancer biomarkers industry study suggests strategies to existing market participants as to how they can improve & reinforce their market position. In addition to this, the study also recommends successful market penetrating strategies for new entrants. Furthermore, cancer biomarkers industry study report has included all major manufacturers and distributors operating in the cancer biomarkers market across all major regions.
Cancer Biomarkers Market Strategic Analysis
Various analytical methods such as Porter’s Five Force Analysis, SWOT analysis, Market Share Analysis, Competitive Analysis, PESTEL Analysis, Market Attractiveness Analysis, and Value Chain Analysis have been used to analyze the market in the research report. These assessments help users of the report in examining and evaluating cancer biomarkers market on the basis of different metrics such as switching costs, economies of scale, current sales, brand loyalty, brand equity, capital investments, production rights, research & development activities, copyrights & patents, legislations, effects of promotional activities, and consumer preferences.
The information provided in our market research report is anticipated to help the industry stakeholders in the effective decision-making process and successful business outcomes. Moreover, we have been using Ansoff Matrix to help firms analyze and plan their business growth strategies.
Additionally, our report contains a growth-share matrix that aids firms’ business decisions for prioritizing their myriad businesses. We have also included GE Nine Cell Matrix that is helpful in making strategic planning and can help firms in determining their position in the market along with analyzing their growth strategies.
Our researchers also make use of the perceptual map to demonstrate how to target consumers feel about a given brand and form perception about it. We have also included the Customer-Based Brand Equity (CBBE) Model for helping firms effectively position their brands.
Cancer Biomarkers Market Key Trends Analysis
The key factors influencing the growth of the cancer biomarkers market have been assessed in the report. Factors having a huge influence on market demand and restraining factors that impact the development of the market are both addressed rigorously & in-depth in our global market research report.
Furthermore, trends that play a key role in market’s growth are discussed comprehensively in the report. Moreover, a large number of qualitative factors or measurements are included in the report and this includes operating risks and major obstacles encountered by players in the industry.
Cancer Biomarkers Market Key Segment Analysis
The report delivers a critical assessment on the cancer biomarkers market by segmenting it based on Products, Applications, and region. All the segments and categories of the cancer biomarkers market have been evaluated based on past, present and future trends and are key parameters determining & defining the growth of the market.
The data for the market and its segments and categories are provided from 2016 to 2028. The report has identified the key segments and categories contributing substantially towards overall market growth in terms of revenue & volume.
Based on Products, the global cancer biomarkers market is segmented into Genetic Biomarkers, Protein Biomarkers, Glyco-biomarkers. Comprehensive qualitative and quantitative this segment analysis will be provided in the report from 2016 to 2028.
Based on Applications, market is divided into Diagnostics, Drug Discovery and Development, Prognostics, Risk Assessment, Others. A slew of business growth opportunities and dynamics affecting the different segments are analyzed and discussed in the report.
Impact Assessment of COVID-19
The COVID-19 outbreak has wreaked havoc on worldwide economic and social systems. The disease has entered several industries' value and supply chains, including the cancer biomarkers market. The government imposed lockdowns in various locations. We will examine the impact of the COVID-19 pandemic on the global market, looking at both demand and supply.
The COVID-19 pandemic's short- and long-term impacts would be explored to provide a summary. This would help build business plans for all market participants, including manufacturers, vendors, suppliers, distributors, and end-users, during and after the epidemic.
Cancer Biomarkers Market Regional Trends and Market Player’s Analysis
On the basis of region, the market is segregated into North America, Latin America, Asia Pacific, Europe, and the Middle East & Africa.
The major players holding a huge chunk of market share in the global cancer biomarkers market and impacting market profitability are evaluated after considering their product & services revenue, sales, business plans, innovations, and growth rate. The final position of a player in the market depends on market events or market happenings, new product launches, mergers & acquisitions, benchmarking, regional expansions, and technical innovations.
For all the key stakeholders of the market, value chain and technology ecosystem, as well as the information provided in this market research report, will prove beneficial. The study offers an outline of the company’s market share and an extensive summary of the major players in the cancer biomarkers market.
Some of the leading players profiled in the global cancer biomarkers market are,
- QIAGEN
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc
- Exact Sciences Corporation
- Sysmex Corporation
- Quest Diagnostics
- Agilent Technologies
- Hologic
- Abbott Laboratories
- F.Hoffmann-La Roche Ltd
- Roche Diagnostics
- Bristol-Myers Squibb Company
- Becton Dickinson and Company
- Biomérieux SA
- Merck KGaA
- Illumina
The Key Audiences for Cancer Biomarkers Market Report
- Research Institutes & consulting firms
- Industry Leaders, as well as companies, aspiring to enter the cancer biomarkers market
- Student and universities
- Solution Providers, product providers, service providers, and other players in the industry
- Associated private firms and government bodies
- Individuals interested to learn about market
The report segments of the global cancer biomarkers market are as follows:
Global Cancer Biomarkers Market: By Products
- Genetic Biomarkers
- Protein Biomarkers
- Glyco-biomarkers
Global Cancer Biomarkers Market: By Applications
- Diagnostics
- Drug Discovery and Development
- Prognostics
- Risk Assessment
- Others
The Most Important Research Methodologies
Primary sources include industry experts from management corporations, processing organizations, and analytical service providers who serve businesses across the sector's value chain. We interviewed key sources to acquire qualitative and quantitative data and analyse future prospects.
Primary research undertaken for this report comprised interviews with industry professionals such as CEOs, Vice Presidents, Marketing Directors and Technology Directors of strong core organizations and institutions in major cancer biomarkers . We interviewed them to get qualitative and quantitative data.
The following are the justifications for purchasing the global Cancer Biomarkers market report:
- Statistical data is well-referenced, and the source is a significant resource for directing interested companies.
- Market development trends and marketing channels that are cutting-edge are discussed.
- The feasibility and growth rate of the market as a whole over the foreseeable future are determined.
- The competitive landscape and demographic research provide a clear picture of the current state of the market on an international scale.
- A thorough examination of development policies and plans, manufacturing processes, and costing provides a more accurate picture of import/export consumption, supply and demand, pricing, revenue, and gross margins, among other things.
- Customization is possible based on the client's requirements.
Frequently Asked Questions
- QIAGEN
- Thermo Fisher Scientific Inc.
- Bio-Rad Laboratories Inc
- Exact Sciences Corporation
- Sysmex Corporation
- Quest Diagnostics
- Agilent Technologies
- Hologic
- Abbott Laboratories
- F.Hoffmann-La Roche Ltd
- Roche Diagnostics
- Bristol-Myers Squibb Company
- Becton Dickinson and Company
- Biomérieux SA
- Merck KGaA
- Illumina
Table Of Content
Table of Content 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Regulatory Scenario by Region/Country 1.4 Market Investment Scenario Strategic 1.5 Market Analysis by Type 1.5.1 Global Cancer Biomarkers Market Share by Type (2020-2026) 1.5.2 Genetic Biomarkers 1.5.3 Protein Biomarkers 1.5.4 Glyco-biomarkers 1.6 Market by Application 1.6.1 Global Cancer Biomarkers Market Share by Application (2020-2026) 1.6.2 Diagnostics 1.6.3 Drug Discovery and Development 1.6.4 Prognostics 1.6.5 Risk Assessment 1.6.6 Others 1.7 Cancer Biomarkers Industry Development Trends under COVID-19 Outbreak 1.7.1 Global COVID-19 Status Overview 1.7.2 Influence of COVID-19 Outbreak on Cancer Biomarkers Industry Development 2. Global Market Growth Trends 2.1 Industry Trends 2.1.1 SWOT Analysis 2.1.2 Porter’s Five Forces Analysis 2.2 Potential Market and Growth Potential Analysis 2.3 Industry News and Policies by Regions 2.3.1 Industry News 2.3.2 Industry Policies 2.4 Industry Trends Under COVID-19 3 Value Chain of Cancer Biomarkers Market 3.1 Value Chain Status 3.2 Cancer Biomarkers Manufacturing Cost Structure Analysis 3.2.1 Production Process Analysis 3.2.2 Manufacturing Cost Structure of Cancer Biomarkers 3.2.3 Labor Cost of Cancer Biomarkers 3.2.3.1 Labor Cost of Cancer Biomarkers Under COVID-19 3.3 Sales and Marketing Model Analysis 3.4 Downstream Major Customer Analysis (by Region) 3.5 Value Chain Status Under COVID-19 4 Players Profiles 4.1 QIAGEN 4.1.1 QIAGEN Basic Information 4.1.2 Cancer Biomarkers Product Profiles, Application and Specification 4.1.3 QIAGEN Cancer Biomarkers Market Performance (2015-2020) 4.1.4 QIAGEN Business Overview 4.2 Thermo Fisher Scientific, Inc. 4.2.1 Thermo Fisher Scientific, Inc. Basic Information 4.2.2 Cancer Biomarkers Product Profiles, Application and Specification 4.2.3 Thermo Fisher Scientific, Inc. Cancer Biomarkers Market Performance (2015-2020) 4.2.4 Thermo Fisher Scientific, Inc. Business Overview 4.3 Bio-Rad Laboratories, Inc 4.3.1 Bio-Rad Laboratories, Inc Basic Information 4.3.2 Cancer Biomarkers Product Profiles, Application and Specification 4.3.3 Bio-Rad Laboratories, Inc Cancer Biomarkers Market Performance (2015-2020) 4.3.4 Bio-Rad Laboratories, Inc Business Overview 4.4 Exact Sciences Corporation 4.4.1 Exact Sciences Corporation Basic Information 4.4.2 Cancer Biomarkers Product Profiles, Application and Specification 4.4.3 Exact Sciences Corporation Cancer Biomarkers Market Performance (2015-2020) 4.4.4 Exact Sciences Corporation Business Overview 4.5 Sysmex Corporation 4.5.1 Sysmex Corporation Basic Information 4.5.2 Cancer Biomarkers Product Profiles, Application and Specification 4.5.3 Sysmex Corporation Cancer Biomarkers Market Performance (2015-2020) 4.5.4 Sysmex Corporation Business Overview 4.6 Quest Diagnostics 4.6.1 Quest Diagnostics Basic Information 4.6.2 Cancer Biomarkers Product Profiles, Application and Specification 4.6.3 Quest Diagnostics Cancer Biomarkers Market Performance (2015-2020) 4.6.4 Quest Diagnostics Business Overview 4.7 Agilent Technologies 4.7.1 Agilent Technologies Basic Information 4.7.2 Cancer Biomarkers Product Profiles, Application and Specification 4.7.3 Agilent Technologies Cancer Biomarkers Market Performance (2015-2020) 4.7.4 Agilent Technologies Business Overview 4.8 Hologic 4.8.1 Hologic Basic Information 4.8.2 Cancer Biomarkers Product Profiles, Application and Specification 4.8.3 Hologic Cancer Biomarkers Market Performance (2015-2020) 4.8.4 Hologic Business Overview 4.9 Abbott Laboratories 4.9.1 Abbott Laboratories Basic Information 4.9.2 Cancer Biomarkers Product Profiles, Application and Specification 4.9.3 Abbott Laboratories Cancer Biomarkers Market Performance (2015-2020) 4.9.4 Abbott Laboratories Business Overview 4.10 F.Hoffmann-La Roche Ltd 4.10.1 F.Hoffmann-La Roche Ltd Basic Information 4.10.2 Cancer Biomarkers Product Profiles, Application and Specification 4.10.3 F.Hoffmann-La Roche Ltd Cancer Biomarkers Market Performance (2015-2020) 4.10.4 F.Hoffmann-La Roche Ltd Business Overview 4.11 Roche Diagnostics 4.11.1 Roche Diagnostics Basic Information 4.11.2 Cancer Biomarkers Product Profiles, Application and Specification 4.11.3 Roche Diagnostics Cancer Biomarkers Market Performance (2015-2020) 4.11.4 Roche Diagnostics Business Overview 4.12 Bristol-Myers Squibb Company 4.12.1 Bristol-Myers Squibb Company Basic Information 4.12.2 Cancer Biomarkers Product Profiles, Application and Specification 4.12.3 Bristol-Myers Squibb Company Cancer Biomarkers Market Performance (2015-2020) 4.12.4 Bristol-Myers Squibb Company Business Overview 4.13 Becton, Dickinson and Company 4.13.1 Becton, Dickinson and Company Basic Information 4.13.2 Cancer Biomarkers Product Profiles, Application and Specification 4.13.3 Becton, Dickinson and Company Cancer Biomarkers Market Performance (2015-2020) 4.13.4 Becton, Dickinson and Company Business Overview 4.14 Biomérieux SA 4.14.1 Biomérieux SA Basic Information 4.14.2 Cancer Biomarkers Product Profiles, Application and Specification 4.14.3 Biomérieux SA Cancer Biomarkers Market Performance (2015-2020) 4.14.4 Biomérieux SA Business Overview 4.15 Merck KGaA 4.15.1 Merck KGaA Basic Information 4.15.2 Cancer Biomarkers Product Profiles, Application and Specification 4.15.3 Merck KGaA Cancer Biomarkers Market Performance (2015-2020) 4.15.4 Merck KGaA Business Overview 4.16 Illumina 4.16.1 Illumina Basic Information 4.16.2 Cancer Biomarkers Product Profiles, Application and Specification 4.16.3 Illumina Cancer Biomarkers Market Performance (2015-2020) 4.16.4 Illumina Business Overview 5 Global Cancer Biomarkers Market Analysis by Regions 5.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Regions 5.1.1 Global Cancer Biomarkers Sales by Regions (2015-2020) 5.1.2 Global Cancer Biomarkers Revenue by Regions (2015-2020) 5.2 North America Cancer Biomarkers Sales and Growth Rate (2015-2020) 5.3 Europe Cancer Biomarkers Sales and Growth Rate (2015-2020) 5.4 Asia-Pacific Cancer Biomarkers Sales and Growth Rate (2015-2020) 5.5 Middle East and Africa Cancer Biomarkers Sales and Growth Rate (2015-2020) 5.6 South America Cancer Biomarkers Sales and Growth Rate (2015-2020) 6 North America Cancer Biomarkers Market Analysis by Countries 6.1 North America Cancer Biomarkers Sales, Revenue and Market Share by Countries 6.1.1 North America Cancer Biomarkers Sales by Countries (2015-2020) 6.1.2 North America Cancer Biomarkers Revenue by Countries (2015-2020) 6.1.3 North America Cancer Biomarkers Market Under COVID-19 6.2 United States Cancer Biomarkers Sales and Growth Rate (2015-2020) 6.2.1 United States Cancer Biomarkers Market Under COVID-19 6.3 Canada Cancer Biomarkers Sales and Growth Rate (2015-2020) 6.4 Mexico Cancer Biomarkers Sales and Growth Rate (2015-2020) 7 Europe Cancer Biomarkers Market Analysis by Countries 7.1 Europe Cancer Biomarkers Sales, Revenue and Market Share by Countries 7.1.1 Europe Cancer Biomarkers Sales by Countries (2015-2020) 7.1.2 Europe Cancer Biomarkers Revenue by Countries (2015-2020) 7.1.3 Europe Cancer Biomarkers Market Under COVID-19 7.2 Germany Cancer Biomarkers Sales and Growth Rate (2015-2020) 7.2.1 Germany Cancer Biomarkers Market Under COVID-19 7.3 UK Cancer Biomarkers Sales and Growth Rate (2015-2020) 7.3.1 UK Cancer Biomarkers Market Under COVID-19 7.4 France Cancer Biomarkers Sales and Growth Rate (2015-2020) 7.4.1 France Cancer Biomarkers Market Under COVID-19 7.5 Italy Cancer Biomarkers Sales and Growth Rate (2015-2020) 7.5.1 Italy Cancer Biomarkers Market Under COVID-19 7.6 Spain Cancer Biomarkers Sales and Growth Rate (2015-2020) 7.6.1 Spain Cancer Biomarkers Market Under COVID-19 7.7 Russia Cancer Biomarkers Sales and Growth Rate (2015-2020) 7.7.1 Russia Cancer Biomarkers Market Under COVID-19 8 Asia-Pacific Cancer Biomarkers Market Analysis by Countries 8.1 Asia-Pacific Cancer Biomarkers Sales, Revenue and Market Share by Countries 8.1.1 Asia-Pacific Cancer Biomarkers Sales by Countries (2015-2020) 8.1.2 Asia-Pacific Cancer Biomarkers Revenue by Countries (2015-2020) 8.1.3 Asia-Pacific Cancer Biomarkers Market Under COVID-19 8.2 China Cancer Biomarkers Sales and Growth Rate (2015-2020) 8.2.1 China Cancer Biomarkers Market Under COVID-19 8.3 Japan Cancer Biomarkers Sales and Growth Rate (2015-2020) 8.3.1 Japan Cancer Biomarkers Market Under COVID-19 8.4 South Korea Cancer Biomarkers Sales and Growth Rate (2015-2020) 8.4.1 South Korea Cancer Biomarkers Market Under COVID-19 8.5 Australia Cancer Biomarkers Sales and Growth Rate (2015-2020) 8.6 India Cancer Biomarkers Sales and Growth Rate (2015-2020) 8.6.1 India Cancer Biomarkers Market Under COVID-19 8.7 Southeast Asia Cancer Biomarkers Sales and Growth Rate (2015-2020) 8.7.1 Southeast Asia Cancer Biomarkers Market Under COVID-19 9 Middle East and Africa Cancer Biomarkers Market Analysis by Countries 9.1 Middle East and Africa Cancer Biomarkers Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Cancer Biomarkers Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Cancer Biomarkers Revenue by Countries (2015-2020) 9.1.3 Middle East and Africa Cancer Biomarkers Market Under COVID-19 9.2 Saudi Arabia Cancer Biomarkers Sales and Growth Rate (2015-2020) 9.3 UAE Cancer Biomarkers Sales and Growth Rate (2015-2020) 9.4 Egypt Cancer Biomarkers Sales and Growth Rate (2015-2020) 9.5 Nigeria Cancer Biomarkers Sales and Growth Rate (2015-2020) 9.6 South Africa Cancer Biomarkers Sales and Growth Rate (2015-2020) 10 South America Cancer Biomarkers Market Analysis by Countries 10.1 South America Cancer Biomarkers Sales, Revenue and Market Share by Countries 10.1.1 South America Cancer Biomarkers Sales by Countries (2015-2020) 10.1.2 South America Cancer Biomarkers Revenue by Countries (2015-2020) 10.1.3 South America Cancer Biomarkers Market Under COVID-19 10.2 Brazil Cancer Biomarkers Sales and Growth Rate (2015-2020) 10.2.1 Brazil Cancer Biomarkers Market Under COVID-19 10.3 Argentina Cancer Biomarkers Sales and Growth Rate (2015-2020) 10.4 Columbia Cancer Biomarkers Sales and Growth Rate (2015-2020) 10.5 Chile Cancer Biomarkers Sales and Growth Rate (2015-2020) 11 Global Cancer Biomarkers Market Segment by Types 11.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Types (2015-2020) 11.1.1 Global Cancer Biomarkers Sales and Market Share by Types (2015-2020) 11.1.2 Global Cancer Biomarkers Revenue and Market Share by Types (2015-2020) 11.2 Genetic Biomarkers Sales and Price (2015-2020) 11.3 Protein Biomarkers Sales and Price (2015-2020) 11.4 Glyco-biomarkers Sales and Price (2015-2020) 12 Global Cancer Biomarkers Market Segment by Applications 12.1 Global Cancer Biomarkers Sales, Revenue and Market Share by Applications (2015-2020) 12.1.1 Global Cancer Biomarkers Sales and Market Share by Applications (2015-2020) 12.1.2 Global Cancer Biomarkers Revenue and Market Share by Applications (2015-2020) 12.2 Diagnostics Sales, Revenue and Growth Rate (2015-2020) 12.3 Drug Discovery and Development Sales, Revenue and Growth Rate (2015-2020) 12.4 Prognostics Sales, Revenue and Growth Rate (2015-2020) 12.5 Risk Assessment Sales, Revenue and Growth Rate (2015-2020) 12.6 Others Sales, Revenue and Growth Rate (2015-2020) 13 Cancer Biomarkers Market Forecast by Regions (2020-2026) 13.1 Global Cancer Biomarkers Sales, Revenue and Growth Rate (2020-2026) 13.2 Cancer Biomarkers Market Forecast by Regions (2020-2026) 13.2.1 North America Cancer Biomarkers Market Forecast (2020-2026) 13.2.2 Europe Cancer Biomarkers Market Forecast (2020-2026) 13.2.3 Asia-Pacific Cancer Biomarkers Market Forecast (2020-2026) 13.2.4 Middle East and Africa Cancer Biomarkers Market Forecast (2020-2026) 13.2.5 South America Cancer Biomarkers Market Forecast (2020-2026) 13.3 Cancer Biomarkers Market Forecast by Types (2020-2026) 13.4 Cancer Biomarkers Market Forecast by Applications (2020-2026) 13.5 Cancer Biomarkers Market Forecast Under COVID-19 14 Appendix 14.1 Methodology 14.2 Research Data Source
Inquiry For Buying
Cancer Biomarkers
Request Sample
Cancer Biomarkers
